March 1, 2022
AbbVie Acquires V-Bio Ventures’s Portfolio Company Syndesi Therapeutics
V-Bio Ventures has announced the completion the acquisition of its portfolio company Syndesi Therapeutics SA by AbbVie (NYSE: ABBV), which…